<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">35082326</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>26</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Identification of let-7f and miR-338 as plasma-based biomarkers for sporadic amyotrophic lateral sclerosis using meta-analysis and empirical validation.</ArticleTitle><Pagination><StartPage>1373</StartPage><MedlinePgn>1373</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1373</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-022-05067-4</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a lethal neurodegenerative disease that in most cases occurs sporadic (sALS). The disease is not curable, and its pathogenesis mechanisms are not well understood yet. Given the intricacy of underlying molecular interactions and heterogeneity of ALS, the discovery of molecules contributing to disease onset and progression will open a new avenue for advancement in early diagnosis and therapeutic intervention. Here we conducted a meta-analysis of 12 circulating miRNA profiling studies using the robust rank aggregation (RRA) method, followed by enrichment analysis and experimental verification. We identified miR-451a and let-7f-5p as meta-signature miRNAs whose targets are involved in critical pathogenic pathways underlying ALS, including 'FoxO signaling pathway', 'MAPK signaling pathway', and 'apoptosis'. A systematic review of 7 circulating gene profiling studies elucidated that 241 genes up-regulated in sALS circulation with concomitant being targets of the meta-signature miRNAs. Protein-protein interaction (PPI) network analysis of the candidate targets using MCODE algorithm revealed the main subcluster is involved in multiple cascades eventually leads apoptosis, including 'positive regulation of neuron apoptosis. Besides, we validated the meta-analysis results using RT-qPCR. Indeed, relative expression analysis verified let-7f-5p and miR-338-3p as significantly down-regulated and up-regulated biomarkers in the plasma of sALS patients, respectively. Receiver operating characteristic (ROC) analysis also highlighted the let-7f-5p and miR-338-3p potential as robustness plasma biomarkers for diagnosis and potential therapeutic targets of sALS disease.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Daneshafrooz</LastName><ForeName>Narges</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Cellular and Molecular Research Center, Department of Neuroscience, Faculty of Advanced Technologies in Medicine, Iran University of Medical Science, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joghataei</LastName><ForeName>Mohammad Taghi</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Cellular and Molecular Research Center, Department of Neuroscience, Faculty of Advanced Technologies in Medicine, Iran University of Medical Science, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehdizadeh</LastName><ForeName>Mehdi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Reproductive Sciences and Technology Research Center, Department of Anatomy, School of Medicine, Iran University of Medical Science, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alavi</LastName><ForeName>Afagh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barati</LastName><ForeName>Mahmood</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Biotechnology, Faculty of Allied Medicine, Iran University of Medical Science, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Panahi</LastName><ForeName>Bahman</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Genomics, Branch for Northwest &amp; West Region, Agricultural Biotechnology Research Institute of Iran (ABRII), Agricultural Research, Education and Extension Organization (AREEO), Tabriz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teimourian</LastName><ForeName>Shahram</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, School of Medicine, Iran University of Medical Science, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zamani</LastName><ForeName>Babak</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Firoozgar Hospital, School of Medicine, Iran University of Medical Science, Tehran, Iran. zamaniba3@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000074166">Circulating MicroRNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C532050">MIRN338 microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000074166" MajorTopicYN="N">Circulating MicroRNA</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015536" MajorTopicYN="N">Down-Regulation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036262" MajorTopicYN="N">Empirical Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060066" MajorTopicYN="N">Protein Interaction Maps</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060888" MajorTopicYN="N">Real-Time Polymerase Chain Reaction</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>27</Day><Hour>5</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35082326</ArticleId><ArticleId IdType="pmc">PMC8791978</ArticleId><ArticleId IdType="doi">10.1038/s41598-022-05067-4</ArticleId><ArticleId IdType="pii">10.1038/s41598-022-05067-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cleveland DW, Rothstein JD. From Charcot to Lou Gehrig: Deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2001;2(11):806&#x2013;819.</Citation><ArticleIdList><ArticleId IdType="pubmed">11715057</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricci C, Marzocchi C, Battistini S. MicroRNAs as biomarkers in amyotrophic lateral sclerosis. Cells. 2018;7(11):219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6262636</ArticleId><ArticleId IdType="pubmed">30463376</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogden A, Foley G, Henderson RD, James N, Aoun SM. Amyotrophic lateral sclerosis: Improving care with a multidisciplinary approach. J. Multidiscip. Healthc. 2017;10:205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5446964</ArticleId><ArticleId IdType="pubmed">28579792</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinchetti P, Rizzuti M, Faravelli I, Corti S. MicroRNA metabolism and dysregulation in amyotrophic lateral sclerosis. Mol. Neurobiol. 2018;55(3):2617&#x2013;2630.</Citation><ArticleIdList><ArticleId IdType="pubmed">28421535</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawahara Y, Mieda-Sato A. TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc. Natl. Acad. Sci. 2012;109(9):3347&#x2013;3352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3295278</ArticleId><ArticleId IdType="pubmed">22323604</ArticleId></ArticleIdList></Reference><Reference><Citation>Panahi B, Mohammadi SA, Ebrahimie E. Identification of miRNAs and their potential targets in halophyte plant Thellungiella halophila. BioTechnol. J. Biotechnol. Comput. Biol. Bionanotechnol. 2013;94(3):285&#x2013;290.</Citation></Reference><Reference><Citation>Panahi B, Mohammadi SA, Khaksefidi RE, Mehrabadi JF, Ebrahimie E. Genome-wide analysis of alternative splicing events in Hordeum vulgare: Highlighting retention of intron-based splicing and its possible function through network analysis. FEBS Lett. 2015;589(23):3564&#x2013;3575.</Citation><ArticleIdList><ArticleId IdType="pubmed">26454178</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L, Sun B, Wu Q, Yang S, Chen F. miRNA&#x2013;miRNA interaction implicates for potential mutual regulatory pattern. Gene. 2012;511(2):187&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pubmed">23031806</ArticleId></ArticleIdList></Reference><Reference><Citation>De Felice B, Guida M, Guida M, Coppola C, De Mieri G, Cotrufo R. A miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis. Gene. 2012;508(1):35&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">22903028</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravnik-Glava&#x10d; M, Glava&#x10d; D. Circulating RNAs as potential biomarkers in amyotrophic lateral sclerosis. Int. J. Mol. Sci. 2020;21(5):1714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7084402</ArticleId><ArticleId IdType="pubmed">32138249</ArticleId></ArticleIdList></Reference><Reference><Citation>Dardiotis E, Aloizou A-M, Siokas V, Patrinos GP, Deretzi G, Mitsias P, et al. The role of microRNAs in patients with amyotrophic lateral sclerosis. J. Mol. Neurosci. 2018;66(4):617&#x2013;628.</Citation><ArticleIdList><ArticleId IdType="pubmed">30415446</ArticleId></ArticleIdList></Reference><Reference><Citation>Foggin SA, Dajas-Bailador F, Mesquita-Ribeiro R, Layfield R. Biological significance of microRNA biomarkers in ALS-innocent bystanders or disease culprits? Front. Neurol. 2019;10:578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6579821</ArticleId><ArticleId IdType="pubmed">31244752</ArticleId></ArticleIdList></Reference><Reference><Citation>Joilin G, Leigh PN, Newbury SF, Hafezparast M. An overview of MicroRNAs as biomarkers of ALS. Front. Neurol. 2019;10:186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6416171</ArticleId><ArticleId IdType="pubmed">30899244</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolde R, Laur S, Adler P, Vilo J. Robust rank aggregation for gene list integration and meta-analysis. Bioinformatics. 2012;28(4):573&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278763</ArticleId><ArticleId IdType="pubmed">22247279</ArticleId></ArticleIdList></Reference><Reference><Citation>Ru Y, Kechris KJ, Tabakoff B, Hoffman P, Radcliffe RA, Bowler R, et al. The multiMiR R package and database: Integration of microRNA&#x2013;target interactions along with their disease and drug associations. Nucleic Acids Res. 2014;42(17):e133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4176155</ArticleId><ArticleId IdType="pubmed">25063298</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, et al. Enrichr: A comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44(W1):W90&#x2013;W97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4987924</ArticleId><ArticleId IdType="pubmed">27141961</ArticleId></ArticleIdList></Reference><Reference><Citation>Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, et al. ClueGO: A Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009;25(8):1091&#x2013;1093.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2666812</ArticleId><ArticleId IdType="pubmed">19237447</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: Protein&#x2013;protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607&#x2013;D613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6323986</ArticleId><ArticleId IdType="pubmed">30476243</ArticleId></ArticleIdList></Reference><Reference><Citation>Bader GD, Hogue CW. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinform. 2003;4(1):2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC149346</ArticleId><ArticleId IdType="pubmed">12525261</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin C-H, Chen S-H, Wu H-H, Ho C-W, Ko M-T, Lin C-Y. cytoHubba: Identifying hub objects and sub-networks from complex interactome. BMC Syst. Biol. 2014;8(S4):S11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4290687</ArticleId><ArticleId IdType="pubmed">25521941</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat. Protoc. 2008;3(6):1101&#x2013;1108.</Citation><ArticleIdList><ArticleId IdType="pubmed">18546601</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O, Siddiqui S, Gabriely G, Lanser AJ, Dake B, Murugaiyan G, et al. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J. Clin. Investig. 2012;122(9):3063&#x2013;3087.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3428086</ArticleId><ArticleId IdType="pubmed">22863620</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi I, Hama Y, Matsushima M, Hirotani M, Kano T, Hohzen H, et al. Identification of plasma microRNAs as a biomarker of sporadic amyotrophic lateral sclerosis. Mol. Brain. 2015;8(1):67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4619470</ArticleId><ArticleId IdType="pubmed">26497046</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A, M&#xfc;ller K, Zondler L, Weydt P, Mayer B, von Arnim CA, et al. Serum microRNAs in sporadic amyotrophic lateral sclerosis. Neurobiol. Aging. 2015;36(9):2660.</Citation><ArticleIdList><ArticleId IdType="pubmed">26142125</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Wei Q, Chen X, Li C, Cao B, Ou R, et al. Aberration of miRNAs expression in leukocytes from sporadic amyotrophic lateral sclerosis. Front. Mol. Neurosci. 2016;9:69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4987348</ArticleId><ArticleId IdType="pubmed">27582688</ArticleId></ArticleIdList></Reference><Reference><Citation>Benigni M, Ricci C, Jones AR, Giannini F, Al-Chalabi A, Battistini S. Identification of miRNAs as potential biomarkers in cerebrospinal fluid from amyotrophic lateral sclerosis patients. NeuroMol. Med. 2016;18(4):551&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pubmed">27119371</ArticleId></ArticleIdList></Reference><Reference><Citation>Waller R, Wyles M, Heath PR, Kazoka M, Wollff H, Shaw PJ, et al. Small RNA sequencing of sporadic amyotrophic lateral sclerosis cerebrospinal fluid reveals differentially expressed miRNAs related to neural and glial activity. Front. Neurosci. 2018;11:731.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5767269</ArticleId><ArticleId IdType="pubmed">29375285</ArticleId></ArticleIdList></Reference><Reference><Citation>Waller R, Goodall EF, Milo M, Cooper-Knock J, Da Costa M, Hobson E, et al. Serum miRNAs miR-206, 143&#x2013;3p and 374b&#x2013;5p as potential biomarkers for amyotrophic lateral sclerosis (ALS) Neurobiol. Aging. 2017;55:123&#x2013;131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5455071</ArticleId><ArticleId IdType="pubmed">28454844</ArticleId></ArticleIdList></Reference><Reference><Citation>Raheja R, Regev K, Healy BC, Mazzola MA, Beynon V, Von Glehn F, et al. Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis. Muscle Nerve. 2018;58(2):261&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6103911</ArticleId><ArticleId IdType="pubmed">29466830</ArticleId></ArticleIdList></Reference><Reference><Citation>De Felice B, Manfellotto F, Fiorentino G, Annunziata A, Biffali E, Pannone R, et al. Wide-ranging analysis of MicroRNA profiles in sporadic amyotrophic lateral sclerosis using next-generation sequencing. Front. Genet. 2018;9:310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6102490</ArticleId><ArticleId IdType="pubmed">30154826</ArticleId></ArticleIdList></Reference><Reference><Citation>Liguori M, Nuzziello N, Introna A, Consiglio A, Licciulli F, D&#x2019;Errico E, et al. Dysregulation of MicroRNAs and target genes networks in peripheral blood of patients with sporadic amyotrophic lateral sclerosis. Front. Mol. Neurosci. 2018;11:288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6121079</ArticleId><ArticleId IdType="pubmed">30210287</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsu M, Hama Y, Utsumi J, Takashina K, Yasumatsu H, Mori F, et al. MicroRNA expression profiles of neuron-derived extracellular vesicles in plasma from patients with amyotrophic lateral sclerosis. Neurosci. Lett. 2019;708:134176.</Citation><ArticleIdList><ArticleId IdType="pubmed">31173847</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa M, Furumichi M, Sato Y, Ishiguro-Watanabe M, Tanabe M. KEGG: Integrating viruses and cellular organisms. Nucleic Acids Res. 2021;49(D1):D545&#x2013;D551.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7779016</ArticleId><ArticleId IdType="pubmed">33125081</ArticleId></ArticleIdList></Reference><Reference><Citation>Blondal T, Nielsen SJ, Baker A, Andreasen D, Mouritzen P, Teilum MW, et al. Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods. 2013;59(1):S1&#x2013;S6.</Citation><ArticleIdList><ArticleId IdType="pubmed">23036329</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronnevi LO, Conradi S. Increased fragility of erythrocytes from amyotrophic lateral sclerosis (ALS) patients provoked by mechanical stress. Acta Neurol. Scand. 1984;69(1):20&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">6702416</ArticleId></ArticleIdList></Reference><Reference><Citation>Dilmaghani NA, Hussen BM, Nateghinia S, Taheri M, Ghafouri-Fard S. Emerging role of microRNAs in the pathogenesis of amyotrophic lateral sclerosis. Metab. Brain Dis. 2021;2021:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">33604874</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai H, Wu S. miR-451: A novel biomarker and potential therapeutic target for cancer. Oncol. Targets. Ther. 2019;12:11069.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6924581</ArticleId><ArticleId IdType="pubmed">31908476</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Hu Y, Zhang M, Yan Y, Yu H, Ge L. microRNA-451 protects neurons against ischemia/reperfusion injury-induced cell death by targeting CELF2. Neuropsychiatr. Dis. Treat. 2018;14:2773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6205134</ArticleId><ArticleId IdType="pubmed">30425495</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon V, Ghaffari S. Transcription factors FOXO in the regulation of homeostatic hematopoiesis. Curr. Opin. Hematol. 2018;25(4):290.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7012318</ArticleId><ArticleId IdType="pubmed">29782339</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz J, Takousis P, Wohlers I, Itua IO, Dobricic V, R&#xfc;cker G, et al. Meta-analyses identify differentially expressed microRNAs in Parkinson's disease. Ann. Neurol. 2019;85(6):835&#x2013;851.</Citation><ArticleIdList><ArticleId IdType="pubmed">30990912</ArticleId></ArticleIdList></Reference><Reference><Citation>Roush S, Slack FJ. The let-7 family of microRNAs. Trends Cell Biol. 2008;18(10):505&#x2013;516.</Citation><ArticleIdList><ArticleId IdType="pubmed">18774294</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairchild CL, Cheema SK, Wong J, Hino K, Sim&#xf3; S, La Torre A. Let-7 regulates cell cycle dynamics in the developing cerebral cortex and retina. Sci. Rep. 2019;9(1):1&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6814839</ArticleId><ArticleId IdType="pubmed">31653921</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar L, Haque R, Nazir A. Role of microRNA Let-7 in modulating multifactorial aspect of neurodegenerative diseases: An overview. Mol. Neurobiol. 2016;53(5):2787&#x2013;2793.</Citation><ArticleIdList><ArticleId IdType="pubmed">25823513</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z-H, Wang Y-F, He D-D, Zhang X-M, Zhou Y-L, Yue H, et al. Let-7f-5p suppresses Th17 differentiation via targeting STAT3 in multiple sclerosis. Aging. 2019;11(13):4463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6660039</ArticleId><ArticleId IdType="pubmed">31326963</ArticleId></ArticleIdList></Reference><Reference><Citation>Han L, Zhou Y, Zhang R, Wu K, Lu Y, Li Y, et al. MicroRNA Let-7f-5p promotes bone marrow mesenchymal stem cells survival by targeting caspase-3 in alzheimer disease model. Front. Neurosci. 2018;12:333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5972183</ArticleId><ArticleId IdType="pubmed">29872375</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts ME, Wu C, Rubin LL. Suppression of MAP4K4 signaling ameliorates motor neuron degeneration in amyotrophic lateral sclerosis-molecular studies toward new therapeutics. J. Exp. Neurosci. 2019;13:1179069519862798.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6624916</ArticleId><ArticleId IdType="pubmed">31320806</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim EK, Choi E-J. Compromised MAPK signaling in human diseases: an update. Arch. Toxicol. 2015;89(6):867&#x2013;882.</Citation><ArticleIdList><ArticleId IdType="pubmed">25690731</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitra J, Hegde PM, Hegde ML. Loss of endosomal recycling factor RAB11 coupled with complex regulation of MAPK/ERK/AKT signaling in postmortem spinal cord specimens of sporadic amyotrophic lateral sclerosis patients. Mol. Brain. 2019;12(1):55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6567394</ArticleId><ArticleId IdType="pubmed">31196199</ArticleId></ArticleIdList></Reference><Reference><Citation>Toku K, Tanaka J, Yano H, Desaki J, Zhang B, Yang L, et al. Microglial cells prevent nitric oxide-induced neuronal apoptosis in vitro. J. Neurosci. Res. 1998;53(4):415&#x2013;425.</Citation><ArticleIdList><ArticleId IdType="pubmed">9710261</ArticleId></ArticleIdList></Reference><Reference><Citation>Vila M, Przedborski S. Targeting programmed cell death in neurodegenerative diseases. Nat. Rev. Neurosci. 2003;4(5):365&#x2013;375.</Citation><ArticleIdList><ArticleId IdType="pubmed">12728264</ArticleId></ArticleIdList></Reference><Reference><Citation>Eijkelenboom A, Burgering BM. FOXOs: Signalling integrators for homeostasis maintenance. Nat. Rev. Mol. Cell Biol. 2013;14(2):83&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">23325358</ArticleId></ArticleIdList></Reference><Reference><Citation>Santo EE, Paik J. FOXO in neural cells and diseases of the nervous system. Curr. Top. Dev. Biol. 2018;127:105&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5881381</ArticleId><ArticleId IdType="pubmed">29433734</ArticleId></ArticleIdList></Reference><Reference><Citation>Andr&#xe9;s-Benito P, Moreno J, Aso E, Povedano M, Ferrer I. Amyotrophic lateral sclerosis, gene deregulation in the anterior horn of the spinal cord and frontal cortex area 8: Implications in frontotemporal lobar degeneration. Aging. 2017;9(3):823.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5391234</ArticleId><ArticleId IdType="pubmed">28283675</ArticleId></ArticleIdList></Reference><Reference><Citation>Krach F, Batra R, Wheeler EC, Vu AQ, Wang R, Hutt K, et al. Transcriptome&#x2013;pathology correlation identifies interplay between TDP-43 and the expression of its kinase CK1E in sporadic ALS. Acta Neuropathol. 2018;136(3):405&#x2013;423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6215775</ArticleId><ArticleId IdType="pubmed">29881994</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xe9;ger B, Vergani L, Sorar&#xf9; G, Hespel P, Derave W, Gobelet C, et al. Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1. FASEB J. 2006;20(3):583&#x2013;585.</Citation><ArticleIdList><ArticleId IdType="pubmed">16507768</ArticleId></ArticleIdList></Reference><Reference><Citation>Han SM, El Oussini H, Scekic-Zahirovic J, Vibbert J, Cottee P, Prasain JK, et al. VAPB/ALS8 MSP ligands regulate striated muscle energy metabolism critical for adult survival in Caenorhabditis elegans. PLoS Genet. 2013;9(9):e1003738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3764199</ArticleId><ArticleId IdType="pubmed">24039594</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Brault JJ, Schild A, Goldberg AL. Coordinate activation of autophagy and the proteasome pathway by FoxO transcription factor. Autophagy. 2008;4(3):378&#x2013;380.</Citation><ArticleIdList><ArticleId IdType="pubmed">18227643</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C, Watts ME, Rubin LL. MAP4K4 activation mediates motor neuron degeneration in amyotrophic lateral sclerosis. Cell Rep. 2019;26(5):1143&#x2013;1156.</Citation><ArticleIdList><ArticleId IdType="pubmed">30699345</ArticleId></ArticleIdList></Reference><Reference><Citation>Barth&#xe9;l&#xe9;my C, Henderson CE, Pettmann B. Foxo3a induces motoneuron death through the Fas pathway in cooperation with JNK. BMC Neurosci. 2004;5(1):1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC538283</ArticleId><ArticleId IdType="pubmed">15569384</ArticleId></ArticleIdList></Reference><Reference><Citation>Snider J, Kotlyar M, Saraon P, Yao Z, Jurisica I, Stagljar I. Fundamentals of protein interaction network mapping. Mol. Syst. Biol. 2015;11(12):848.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4704491</ArticleId><ArticleId IdType="pubmed">26681426</ArticleId></ArticleIdList></Reference><Reference><Citation>De Felice B, Annunziata A, Fiorentino G, Borra M, Biffali E, Coppola C, et al. miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients. Neurogenetics. 2014;15(4):243&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pubmed">25130371</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou C-H, Shrestha S, Yang C-D, Chang N-W, Lin Y-L, Liao K-W, et al. miRTarBase update 2018: A resource for experimentally validated microRNA-target interactions. Nucleic Acids Res. 2018;46(D1):D296&#x2013;D302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5753222</ArticleId><ArticleId IdType="pubmed">29126174</ArticleId></ArticleIdList></Reference><Reference><Citation>Cadoni MPL, Biggio ML, Arru G, Secchi G, Orr&#xf9; N, Clemente MG, et al. VAPB ER-aggregates, a possible new biomarker in ALS pathology. Cells. 2020;9(1):164.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7017080</ArticleId><ArticleId IdType="pubmed">31936602</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y, Zeng S, Zheng G, Chen D, Li P, Yang M, et al. FOXO3a-driven miRNA signatures suppresses VEGF-A/NRP1 signaling and breast cancer metastasis. Oncogene. 2020;2020:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7843418</ArticleId><ArticleId IdType="pubmed">33262463</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>